Liechti M., Kunz I., and Kupferschmidt H. Acute medical problems due to Ecstasy use. Swiss Medical Weekly 135 (2005) 652-657. Retrieved August 29, 2008, from www.smw.ch/dfe/set_archiv.asp
Office of National Drug Control Policy. National drug control strategy; 2008 annual report (2008). Retrieved August 29, 2008, from www.whitehousedrugpolicy.gov/publications/policy/ndcs08/2008ndcs.pdf
U.S. Department of Health and Human Services. (2008). MDMA (Ecstasy). National Institute on Drug Abuse. Retrieved August 29, 2008, from www.nida.nih.gov/PDF/Infofacts/MDMA08.pdf.
U.S. Department of Health and Human Services. (2008). MDMA (Ecstasy). National Institute on Drug Abuse. Retrieved August 29, 2008, from www.nida.nih.gov/PDF/Infofacts/MDMA08.pdf.
11
57649226282
U.S. Department of Health and Human Services. (2006). Research report series: MDMA (Ecstasy) abuse. National Institute on Drug Abuse. Retrieved August 29, 2008, from www.drugabuse.gov/PDF/RRmdma.pdf.
U.S. Department of Health and Human Services. (2006). Research report series: MDMA (Ecstasy) abuse. National Institute on Drug Abuse. Retrieved August 29, 2008, from www.drugabuse.gov/PDF/RRmdma.pdf.
12
0034720722
Raves: A review of the culture, the drugs and the prevention of harm
Retrieved September 4, 2008, from
Weir E. Raves: A review of the culture, the drugs and the prevention of harm. Canadian Medical Association Journal 162 (2000) 1843-1848. http://www.cmaj.ca/cgi/reprint/162/13/1843 Retrieved September 4, 2008, from
Zagnoni P., and Albano C. Psychostimulants and epilepsy. Epilepsia 43 (2002) 28-31. Retrieved September 4, 2008, from www.3.interscience.wiley.com/cgi-bin/fulltext/118940645/PDFSTART